| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACCS
|
1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACYP2
|
acylphosphatase 2, muscle type
|
|
ADAM29
|
ADAM metallopeptidase domain 29
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AFP
|
alpha-fetoprotein
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AKAP10
|
A kinase (PRKA) anchor protein 10
|
|
AKAP2
|
A kinase (PRKA) anchor protein 2
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKR1A1
|
aldo-keto reductase family 1, member A1 (aldehyde reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKR7A3
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALS2CR12
|
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANKRD62P1-PARP4P3
|
ANKRD62P1-PARP4P3 readthrough, transcribed pseudogene
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ASCC1
|
activating signal cointegrator 1 complex subunit 1
|
|
ASCC3
|
activating signal cointegrator 1 complex subunit 3
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ATF1
|
activating transcription factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AXIN2
|
axin 2
|
|
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BARX1
|
BARX homeobox 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTNL2
|
butyrophilin-like 2
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
CA11
|
carbonic anhydrase XI
|
|
CAMKK1
|
calcium/calmodulin-dependent protein kinase kinase 1, alpha
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPN9
|
calpain 9
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNH
|
cyclin H
|
|
CD14
|
CD14 molecule
|
|
CD24
|
CD24 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD48
|
CD48 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH12
|
cadherin 12, type 2 (N-cadherin 2)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CFAP57
|
cilia and flagella associated protein 57
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CHST5
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5
|
|
CLK2
|
CDC-like kinase 2
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRNN
|
cornulin
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CSK
|
c-src tyrosine kinase
|
|
CTGF
|
connective tissue growth factor
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP39A1
|
cytochrome P450, family 39, subfamily A, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
DAD1
|
defender against cell death 1
|
|
DCAF13
|
DDB1 and CUL4 associated factor 13
|
|
DCC
|
DCC netrin 1 receptor
|
|
DDX20
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DEC1
|
deleted in esophageal cancer 1
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
|
DHX16
|
DEAH (Asp-Glu-Ala-His) box polypeptide 16
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIDO1
|
death inducer-obliterator 1
|
|
DIRC3
|
disrupted in renal carcinoma 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DNAH1
|
dynein, axonemal, heavy chain 1
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DPCR1
|
diffuse panbronchiolitis critical region 1
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DUSP23
|
dual specificity phosphatase 23
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
EPG5
|
ectopic P-granules autophagy protein 5 homolog (C. elegans)
|
|
EPHB1
|
EPH receptor B1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPX
|
eosinophil peroxidase
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ESR1
|
estrogen receptor 1
|
|
EXO1
|
exonuclease 1
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FADS1
|
fatty acid desaturase 1
|
|
FAM3B
|
family with sequence similarity 3, member B
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCE
|
Fanconi anemia, complementation group E
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FARSB
|
phenylalanyl-tRNA synthetase, beta subunit
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FAT2
|
FAT atypical cadherin 2
|
|
FAT4
|
FAT atypical cadherin 4
|
|
FBLN2
|
fibulin 2
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF12
|
fibroblast growth factor 12
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FGFRL1
|
fibroblast growth factor receptor-like 1
|
|
FHIT
|
fragile histidine triad
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXC1
|
forkhead box C1
|
|
FOXF1
|
forkhead box F1
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GALNT13
|
polypeptide N-acetylgalactosaminyltransferase 13
|
|
GEMIN4
|
gem (nuclear organelle) associated protein 4
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GH1
|
growth hormone 1
|
|
GH2
|
growth hormone 2
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJB5
|
gap junction protein, beta 5, 31.1kDa
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNAS
|
GNAS complex locus
|
|
GPAM
|
glycerol-3-phosphate acyltransferase, mitochondrial
|
|
GPANK1
|
G patch domain and ankyrin repeats 1
|
|
GPR158
|
G protein-coupled receptor 158
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX2
|
glutathione peroxidase 2
|
|
GPX3
|
glutathione peroxidase 3
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRIK1
|
glutamate receptor, ionotropic, kainate 1
|
|
GRIN3A
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTT2
|
glutathione S-transferase theta 2 (gene/pseudogene)
|
|
GSTT2B
|
glutathione S-transferase theta 2B (gene/pseudogene)
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GTDC1
|
glycosyltransferase-like domain containing 1
|
|
GTF2H3
|
general transcription factor IIH, polypeptide 3, 34kDa
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
HAPLN1
|
hyaluronan and proteoglycan link protein 1
|
|
HELQ
|
helicase, POLQ-like
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
HUS1B
|
HUS1 checkpoint homolog b (S. pombe)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL18
|
interleukin 18
|
|
IL18RAP
|
interleukin 18 receptor accessory protein
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL27
|
interleukin 27
|
|
IL3
|
interleukin 3
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INSIG2
|
insulin induced gene 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA7
|
integrin, alpha 7
|
|
KCNH1
|
potassium channel, voltage gated eag related subfamily H, member 1
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA0226L
|
KIAA0226-like
|
|
KIF26B
|
kinesin family member 26B
|
|
KLF12
|
Kruppel-like factor 12
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LHX4
|
LIM homeobox 4
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LIG3
|
ligase III, DNA, ATP-dependent
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LOX
|
lysyl oxidase
|
|
LRFN2
|
leucine rich repeat and fibronectin type III domain containing 2
|
|
LRMP
|
lymphoid-restricted membrane protein
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR100
|
microRNA 100
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR125A
|
microRNA 125a
|
|
MIR146A
|
microRNA 146a
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR219A1
|
microRNA 219a-1
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR27A
|
microRNA 27a
|
|
MIR30A
|
microRNA 30a
|
|
MIR30C1
|
microRNA 30c-1
|
|
MIR34B
|
microRNA 34b
|
|
MIR34C
|
microRNA 34c
|
|
MIR373
|
microRNA 373
|
|
MIR423
|
microRNA 423
|
|
MIR492
|
microRNA 492
|
|
MIR499A
|
microRNA 499a
|
|
MIR499B
|
microRNA 499b
|
|
MIR604
|
microRNA 604
|
|
MIR608
|
microRNA 608
|
|
MIR631
|
microRNA 631
|
|
MLH1
|
mutL homolog 1
|
|
MLH3
|
mutL homolog 3
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MROH9
|
maestro heat-like repeat family member 9
|
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-ND3
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
MTCL1
|
microtubule crosslinking factor 1
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFD2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYH3
|
myosin, heavy chain 3, skeletal muscle, embryonic
|
|
MYO9B
|
myosin IXB
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPY
|
neuropeptide Y
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NRP1
|
neuropilin 1
|
|
NRXN1
|
neurexin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPCML
|
opioid binding protein/cell adhesion molecule-like
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PACSIN1
|
protein kinase C and casein kinase substrate in neurons 1
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD5
|
programmed cell death 5
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
PGLYRP2
|
peptidoglycan recognition protein 2
|
|
PGR
|
progesterone receptor
|
|
PHC1
|
polyhomeotic homolog 1 (Drosophila)
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PKP4
|
plakophilin 4
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G5
|
phospholipase A2, group V
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLQ
|
polymerase (DNA directed), theta
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POP1
|
processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae)
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPIP5K1
|
diphosphoinositol pentakisphosphate kinase 1
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRLR
|
prolactin receptor
|
|
PSCA
|
prostate stem cell antigen
|
|
PSD3
|
pleckstrin and Sec7 domain containing 3
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PWAR1
|
Prader Willi/Angelman region RNA 1
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB37
|
RAB37, member RAS oncogene family
|
|
RAD18
|
RAD18 E3 ubiquitin protein ligase
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAD54B
|
RAD54 homolog B (S. cerevisiae)
|
|
RAD54L
|
RAD54-like (S. cerevisiae)
|
|
RAG1
|
recombination activating gene 1
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RET
|
ret proto-oncogene
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS11
|
regulator of G-protein signaling 11
|
|
RGS17
|
regulator of G-protein signaling 17
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RGS6
|
regulator of G-protein signaling 6
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RXRG
|
retinoid X receptor, gamma
|
|
S100A3
|
S100 calcium binding protein A3
|
|
SEPP1
|
selenoprotein P, plasma, 1
|
|
SERPINI2
|
serpin peptidase inhibitor, clade I (pancpin), member 2
|
|
SFTPD
|
surfactant protein D
|
|
SGCD
|
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
|
|
SGPP2
|
sphingosine-1-phosphate phosphatase 2
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A16
|
solute carrier family 22 (organic cation/carnitine transporter), member 16
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC52A3
|
solute carrier family 52 (riboflavin transporter), member 3
|
|
SLC9A9
|
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SSTR1
|
somatostatin receptor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SULF1
|
sulfatase 1
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1C2
|
sulfotransferase family, cytosolic, 1C, member 2
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TDG
|
thymine-DNA glycosylase
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TLN1
|
talin 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TLR9
|
toll-like receptor 9
|
|
TMC5
|
transmembrane channel-like 5
|
|
TMEM173
|
transmembrane protein 173
|
|
TMEM67
|
transmembrane protein 67
|
|
TMPRSS11A
|
transmembrane protease, serine 11A
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TOP1MT
|
topoisomerase (DNA) I, mitochondrial
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53I3
|
tumor protein p53 inducible protein 3
|
|
TP73
|
tumor protein p73
|
|
TRAK2
|
trafficking protein, kinesin binding 2
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIM29
|
tripartite motif containing 29
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2E2
|
ubiquitin-conjugating enzyme E2E 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UNC5CL
|
unc-5 homolog C (C. elegans)-like
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XDH
|
xanthine dehydrogenase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XPO5
|
exportin 5
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
ZBTB20
|
zinc finger and BTB domain containing 20
|
|
ZNF24
|
zinc finger protein 24
|
|
ZNF624
|
zinc finger protein 624
|
|
ZRANB3
|
zinc finger, RAN-binding domain containing 3
|
